Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
SLDB

Solid Biosciences

$33.00

16 (8.00%)

17:14
02/14/19
02/14
17:14
02/14/19
17:14
Hot Stocks
Perceptive Advisors reports 11.1% passive stake in Solid Biosciences »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

16:08
02/14/19
02/14
16:08
02/14/19
16:08
Hot Stocks
Sarepta, Lysogene announce first patient dosed in AAVance trial »

Lysogene and Sarepta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SRPT

Sarepta

16:07
02/14/19
02/14
16:07
02/14/19
16:07
Hot Stocks
Sarepta, Lysogene announce dosing of first patient in AAVance »

Lysogene and Sarepta…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

SRPT

Sarepta

$134.80

1.89 (1.42%)

08:44
02/14/19
02/14
08:44
02/14/19
08:44
Hot Stocks
Sarepta announces FDA acceptance of golodirsen NDA »

Sarepta announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Tuesday
SRPT

Sarepta

$127.00

-0.79 (-0.62%)

08:36
02/12/19
02/12
08:36
02/12/19
08:36
Recommendations
Sarepta analyst commentary at Nomura Instinet »

Nomura expects…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a week ago
ORTX

Orchard Therapeutics

$13.99

1.14 (8.87%)

, SLDB

Solid Biosciences

$7.17

0.02 (0.28%)

11:53
02/08/19
02/08
11:53
02/08/19
11:53
Recommendations
Orchard Therapeutics, Solid Biosciences, Sangamo analyst commentary at Goldman Sachs »

Goldman says Orchard…

ORTX

Orchard Therapeutics

$13.99

1.14 (8.87%)

SLDB

Solid Biosciences

$7.17

0.02 (0.28%)

SGMO

Sangamo

$7.89

-0.455 (-5.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLDB

Solid Biosciences

$7.15

-15.11 (-67.88%)

08:28
02/08/19
02/08
08:28
02/08/19
08:28
Upgrade
Solid Biosciences rating change at Citi »

Citi upgrades Solid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SLDB

Solid Biosciences

$7.15

-15.11 (-67.88%)

06:05
02/08/19
02/08
06:05
02/08/19
06:05
Upgrade
Solid Biosciences rating change at Citi »

Solid Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$62.81

-1.1 (-1.72%)

, GSK

GlaxoSmithKline

$40.57

-0.1 (-0.25%)

04:55
02/08/19
02/08
04:55
02/08/19
04:55
Conference/Events
The Conference Forum to hold a conference »

5th Annual…

C

Citi

$62.81

-1.1 (-1.72%)

GSK

GlaxoSmithKline

$40.57

-0.1 (-0.25%)

DNA

Bought by RHHBY

$0.00

(0.00%)

MRK

Merck

$76.82

-0.58 (-0.75%)

MEDI

Medimmune

$0.00

(0.00%)

NKTR

Nektar

$43.82

-0.51 (-1.15%)

IOVA

Iovance Biotherapeutics

$9.69

-0.16 (-1.62%)

NEO

NeoGenomics

$16.31

-0.24 (-1.45%)

FATE

Fate Therapeutics

$13.33

-0.86 (-6.06%)

MDSO

Medidata

$73.55

-1.59 (-2.12%)

NSTG

NanoString

$22.39

-0.09 (-0.40%)

NTGN

Neon Therapeutics

$5.02

-0.03 (-0.59%)

PRAH

PRA Health

$105.75

-2.25 (-2.08%)

BTAI

BioXcel Therapeutics

$8.25

0.4 (5.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Feb

  • 11

    Feb

  • 12

    Feb

  • 14

    Feb

  • 16

    Feb

  • 19

    Feb

  • 25

    Feb

  • 28

    Feb

  • 02

    Apr

  • 11

    Apr

  • 15

    Apr

  • 18

    May

  • 28

    May

  • 13

    Jul

EDIT

Editas Medicine

$19.44

-1.68 (-7.95%)

17:00
02/07/19
02/07
17:00
02/07/19
17:00
Initiation
Editas Medicine initiated at BTIG »

Editas Medicine initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.